MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2018 International Congress

    Effect of medication on lexical tone production in Cantonese patients with Parkinson’s Disease

    A. Chan, S. Chen, J. Shao, C.C. Zhang, I. Lam, S. Pang, V. Ngan, J. Tam, W.C. Yang, J. Ngan, S. Pinto (Hong Kong)

    Objective: To examine how dysarthria resulting from Parkinson’s Disease (PD) affects lexical tone production in Cantonese-speaking patients and to evaluate the effects of medication Background:…
  • 2018 International Congress

    Vowel characteristics associated with Parkinson’s disease in Cantonese

    N. Leung, E. Tong, M. Ng (Pokfulam, Hong Kong)

    Objective: Dopaminergic treatment has been reported to help motor problem associated with Parkinson's disease (PD), but not speech motor. The current study examined vowel articulation…
  • 2018 International Congress

    Risk estimation in the years preceding diagnosis of Parkinson’s disease in the PREDICT-PD cohort

    S. Auger, D. Rack, J. Bestwick, G. Giovannoni, A. Lees, A. Schrag, A. Noyce (London, United Kingdom)

    Objective: To test and refine the use of probability-based algorithms to identify individuals at high-risk of developing Parkinson’s disease (PD). Background: Neurodegeneration preceding a formal…
  • 2018 International Congress

    GBA haploinsufficiency accelerated alpha synuclein pathology with altered lipid metabolism in a premotor model of Parkinson’s disease

    H. Yamakado, M. Ikuno, H. Akiyama, L. Parajuli, K. Taguchi, J. Hara, N. Uemura, Y. Hatanaka, K. Higaki, M. Tanaka, M. Koike, Y. Hirabayashi, R. Takahashi (Kyoto, Japan)

    Objective: To make Parkinson’s disease (PD) mice model and investigate the mechanism how glucocerebrosidase (gba) heterozygous mutations contribute to asyn pathology and development of PD.…
  • 2018 International Congress

    STN DBS – A study of frequency of gait (fog) in Parkinson’s disease

    V. Rama Raju, R. Borgohain (Hyderabad, India)

    Objective: In search of new techniques to help improve lifestyle of Parkinson`s diseased conditions (PDs), a wireless technique is proposed to identify freeze, reduce freeze,…
  • 2018 International Congress

    Patients with Parkinson’s disease and psychosis have altered structural connectivity of the executive and visual networks

    P. Pal, A. Lenka, M. Ingalhalikar, A. Shah, J. Saini, S. Arumugham, S. Hegde, L. George, R. Yadav (Bangalore, India)

    Objective: To analyze the integrity of visual and executive network of patients with Parkinson’s disease (PD) with psychosis (PD-P) and those without psychosis (PD-NP) and…
  • 2018 International Congress

    The Reliability Study of King’s Parkinson’s Disease Pain Scale in Indonesian Version

    V. Wijaya, R. Pinzon (Yogyakarta, Indonesia)

    Objective: To create the reliable Indonesian Version of King’s Parkinson’s Disease Pain Scale. Background: Pain is one of the most common non-motor symptoms of Parkinson’s…
  • 2018 International Congress

    Efficacy of zonisamide on motor symptoms in dementia with Lewy bodies: A post-hoc analysis of a phase 3 study

    H. Maruyama, M. Murata, T. Odawara, K. Hasegawa, R. Kajiwara, H. Takeuchi, K. Kosaka (Tokyo, Japan)

    Objective: To characterize the efficacy of zonisamide in improving motor symptoms, we performed a post-hoc analysis using data from a phase 3 study that evaluated…
  • 2018 International Congress

    Incremental hourly burden of “OFF” episodes on patient quality of life and health resource use among patients with Parkinson’s disease: A Neurologist/Patient Real World Assessment in the US

    K. Rajagopalan, J. Barton, J. Pike (Marlborough, MA, USA)

    Objective: To investigate the incremental hourly burden of “OFF” episodes on health resource utilization (HRU) and health- related- quality of life (HRQoL) from a real…
  • 2018 International Congress

    Neuromelanin-MRI in REM sleep behaviour disorder predicts dopaminergic dysfunction and clinical risk of Parkinson’s disease

    T. Barber, L. Griffanti, K. Bradley, D. McGowan, M. Crabbe, C. Lo, C. Mackay, J. Klein, M. Hu (Oxford, United Kingdom)

    Objective: To determine whether neuromelanin-MRI signal changes in the substantia nigra and locus coeruleus in patients with REM sleep behaviour disorder (RBD) are predictive of…
  • « Previous Page
  • 1
  • …
  • 234
  • 235
  • 236
  • 237
  • 238
  • …
  • 388
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Nilotinib for treating MSA: A preclinical proof of concept study
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Patients with Essential Tremor Live Longer than their Relatives
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley